Clinical and molecular associations with outcomes at 2 years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK) [0.03%]
急性膝关节损伤后2年临床和分子结局的纵向研究：肯尼迪膝关节损伤队列(KICK)项目的资料分析
Cesar Garriga,Megan Goff,Erin Paterson et al.
Cesar Garriga et al.
Background: Joint injury is a major risk factor for osteoarthritis and provides an opportunity to prospectively examine early processes associated with osteoarthritis. We investigated whether predefined baseline demograph...
The Lancet Rheumatology
The Lancet Rheumatology
Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case series [0.03%]
新型冠状病毒感染所致噬血细胞综合征2例报告
Luke Flower,Nick Laundy,Maryam Khosravi et al.
Luke Flower et al.
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis [0.03%]
安卡拉利对新冠肺炎患者死亡率影响的系统评价和患者级荟萃分析
Evdoxia Kyriazopoulou,Thomas Huet,Giulio Cavalli et al.
Evdoxia Kyriazopoulou et al.
Background: Anakinra might improve the prognosis of patients with moderate to severe COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). We aimed to assess the effect of anakinra ...
A role for interleukin-1 receptor antagonism in severe COVID-19? [0.03%]
白细胞介素-1受体拮抗剂在重症COVID-19中的作用？
Rachel S Tattersall,Dennis McGonagle,Jessica J Manson
Rachel S Tattersall
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies [0.03%]
荷兰自身免疫性疾病患者接种COVID-19疫苗后的抗体产生情况：一项前瞻性队列研究的亚组分析
Laura Boekel,Maurice Steenhuis,Femke Hooijberg et al.
Laura Boekel et al.
Background: Data are scarce on immunogenicity of COVID-19 vaccines in patients with autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to investigate the effect of different immunosuppressiv...
Research in Brief [0.03%]
研究简报
Jennifer Thorley
Jennifer Thorley
Elizabeth R Volkmann
Elizabeth R Volkmann
Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs [0.03%]
LMICs中MIS-C一线治疗：类固醇还是静脉注射免疫球蛋白
Laura Crosby,S Balasubramanian,Athimalaipet V Ramanan
Laura Crosby
Flavia Leone,Pier Giacomo Cerasuolo,Silvia Laura Bosello et al.
Flavia Leone et al.